CD93
Aliases: | C1QR1, C1qR(P), C1qRP, CDw93, ECSM3, MXRA4, dJ737E23.1 |
---|---|
Other: | complement component C1q receptor|C1q receptor 1|C1q/MBL/SPA receptor|C1qR|CD93 antigen|complement component 1 q subcomponent receptor 1|matrix-remodeling-associated protein 4|matrix-remodelling associated 4 |
The protein encoded by this gene is a cell-surface glycoprotein and type I membrane protein that was originally identified as a myeloid cell-specific marker. The encoded protein was once thought to be a receptor for C1q, but now is thought to instead be involved in intercellular adhesion and in the clearance of apoptotic cells. The intracellular cytoplasmic tail of this protein has been found t... see more
Alexa Fluor 532
Common Laser: | 532 |
---|---|
Common Filter: | 575/36 |
Excitation Peak: | 532 |
Emission Peak: | 554 |
Alexa Fluor™ 532 (AF532, Alexa 532) has an excitation peak at 532 nm and an emission peak at 554 nm, and is spectrally similar to Cy®3 (GE Healthcare), TRITC, iFluor® 514 (ATT Bioquest) and iFluor® 546 (ATT Bioquest). Many flow cytometers are equipped with 532nm lasers, so while Alexa 532 can be used for flow cytometry, PE is more commonly used due to its brightness and spectral characteristics... see more
Popular CD93 Alexa Fluor 532 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
Novus Biologicals NBP2-90128AF532 |
ELISA | CD93 Human |
Rabbit IgG 4 |
0.1 ml $518 |
Details | |
Novus Biologicals FAB23791X |
WB,FC | CD93 Human |
Mouse IgG1 273107 |
0.1 ml $503 |
Details | |
Novus Biologicals FAB1696X |
FC,ICC | CD93 Mouse |
Rat IgG2b 223437 |
0.1 ml $503 |
Details | |
Novus Biologicals NBP1-43378AF532 |
WB,FC,ELISA | CD93 Human |
Mouse IgG2b R139 |
0.1 ml $464 |
Details | |
Novus Biologicals NBP2-90892AF532 |
FC | CD93 Rat |
Rabbit IgG 138 |
100 μl $449 |
Details | |
Novus Biologicals NBP2-90894AF532 |
ELISA | CD93 Rat |
Rabbit IgG 164 |
0.1 ml $518 |
Details | |
Browse CD93 / Alexa Fluor 532 antibodies. |